Loading clinical trials...
Loading clinical trials...
Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is the most common complication with high costs, significant morbidity and even mortality. The major mechanisms of PEP is ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
The Second Hospital of Nanjing Medical University
NCT06102382 · Cesarean Section, Hypotension, and more
NCT06311903 · Norepinephrine, Hemorrhagic Shock, and more
NCT05664074 · Post-ERCP Acute Pancreatitis
NCT06844201 · Ephedrine, Norepinephrine, and more
NCT04546867 · Post-ERCP Acute Pancreatitis, Pancreatic Stent, and more
Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions